戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 is of a precursor of raloxifene, a selective estrogen receptor modulator.
2 ass of drugs recently described as selective estrogen receptor modulators.
3 and retinoid X receptor alpha with selective estrogen receptor modulators.
4 by therapy with any one of several selective estrogen receptor modulators.
5 ther evaluation of carborane-based selective estrogen receptor modulators.
6 ssified as both phytoestrogens and selective estrogen receptor modulators.
7 ) have precipitated a search for alternative estrogen receptor modulators.
8 ogenic actions, characteristics of selective estrogen receptor modulators.
9 nic and antiestrogenic activity of selective estrogen receptor modulators.
10 cer are associated with the use of selective estrogen receptor modulators.
11 Leu-Cys)-Arg-Leu-Leu-Gln-NH2 (peptidomimetic estrogen receptor modulator 1), binds with a Ki of 25 nM
12                      A novel SERM (selective estrogen receptor modulators), 1-(R), a chromene-derived
13 ity of ERalpha can be regulated by selective estrogen receptor modulators, a new class of drugs whose
14 nes and patient-derived organoids, selective estrogen receptor modulators, a pure anti-estrogen, and
15 tor degeneration that tamoxifen, a selective estrogen receptor modulator and a drug previously linked
16                               Both selective estrogen receptor modulators and aromatase inhibitors ar
17 is relationship does not extend to selective estrogen receptor modulators and pure antagonists.
18 s for the differential capacity of selective estrogen receptor modulators and selective estrogen rece
19 the identification of two structurally novel estrogen receptor modulators and the accurate prediction
20                                Tamoxifen, an estrogen receptor modulator, and its primary and seconda
21  the determination of idoxifene, a selective estrogen receptor modulator, and its pyrrolidinone metab
22 rs, androgen receptor antagonists, selective estrogen receptor modulators, and aromatase inhibitors a
23 d androgen dehydroepiandrosterone, selective estrogen receptor modulators, and the prolactin inhibito
24 tor potentiator (ivacaftor), and a selective estrogen receptor modulator antimicrobial adjuvant (ralo
25                       Tamoxifen, a selective estrogen receptor modulator approved for the treatment o
26                                    Selective estrogen receptor modulators are an emerging class of ph
27            The preliminary data on selective estrogen receptor modulators are not overly promising, b
28                   We show that the selective estrogen receptor modulator arzoxifene (Arz) and the rex
29 ons among benzothiophene and triarylethylene estrogen receptor modulators can be ascribed to discrete
30                                    Selective estrogen receptor modulator drug molecules of triphenyle
31  (i.e., agonistic) pharmacology of selective estrogen receptor modulator drugs in this pathway report
32                 It also produced a selective estrogen receptor modulator effect as assessed by measur
33 novel allosteric mechanism for the selective estrogen receptor modulator ERalpha complex.
34 n at activating function 2b of the selective estrogen receptor modulator ERalpha complex.
35 ting the estrogen-like activity of selective estrogen receptor modulator-ERalpha complexes.
36           E2 and tamoxifen (TX), a selective estrogen receptor modulator, exerted protection against
37                  Tamoxifen (TX), a selective estrogen receptor modulator, exerts antagonistic effects
38 H) trial showed that raloxifene, a selective estrogen receptor modulator, had no overall effect on th
39                       Tamoxifen, a selective estrogen receptor modulator, has antifibrotic properties
40 stic differences between different selective estrogen receptor modulators have been translated into i
41        Denosumab and toremifene (a selective estrogen receptor modulator) have each been shown to red
42 in the brain, including the use of selective estrogen receptor modulators, high soy diets, or isoflav
43 nce: left breast radiation alone), selective estrogen receptor modulators (HR, 2.0 [95% CI, 1.2 to 3.
44                      Raloxifene, a selective estrogen receptor modulator, improves cardiovascular ris
45 ta and differentially regulated by selective estrogen receptor modulators in a cell line-dependent ma
46 ues can be used for the analysis of selected estrogen receptor modulators in human plasma where more
47 the membrane impermeant E2-BSA and selective estrogen receptor modulators, including a new diphenylac
48              Clomiphene citrate, a selective estrogen receptor modulator, increases estradiol levels
49                                    Selective estrogen receptor modulator is a proven agent for chemop
50 ew structural class of achiral, nonsteroidal estrogen receptor modulators is described.
51  raloxifene (Ral), which is also a selective estrogen receptor modulator, is a complete antiestrogen
52      4-Hydroxytamoxifen (4-OHT), a selective estrogen receptor modulator, is an agonist at a transfor
53                      Raloxifene, a selective estrogen receptor modulator, is currently used for both
54                       Tamoxifen, a selective estrogen receptor modulator, is widely used in research
55 d to test the ability of the novel selective estrogen receptor modulator lasofoxifene (LAS) to inhibi
56              Whether raloxifene, a selective estrogen-receptor modulator, might have similar actions
57      Raloxifene hydrochloride is a selective estrogen receptor modulator (mixed estrogen agonist/anta
58 rapeutic potential of tamoxifen, a selective estrogen receptor modulator, on estrogen-induced lupus.
59 examine the effects of LY117018, a selective estrogen receptor modulator, on peripheral nerve regener
60        The effect of raloxifene, a selective estrogen-receptor modulator, on coronary heart disease (
61 uated the effects of toremifene, a selective estrogen-receptor modulator, on fasting serum lipid leve
62 in combination with more effective selective estrogen receptor modulators or selective receptor downr
63        Raloxifene hydrochloride, a selective estrogen receptor modulator, prevents bone loss in postm
64 ratory reported that raloxifene, a selective estrogen receptor modulator, promoted regression of high
65                                 Based on the estrogen receptor modulator raloxifene, which had previo
66  min after being injected with the selective estrogen receptor modulators, raloxifene, lasofoxifene,
67     Administration of tamoxifen, a selective estrogen-receptor modulator, restored fertility to the D
68         Tamoxifen, a member of the selective estrogen receptor modulator (SERM) family, is widely use
69                                  A selective estrogen receptor modulator (SERM) for the potential tre
70              The design of a novel selective estrogen receptor modulator (SERM) for the potential tre
71 fene, tamoxifen, and nonusers of a selective estrogen receptor modulator (SERM) in the general popula
72 thylene bisphenol analogues of the selective estrogen receptor modulator (SERM) tamoxifen were synthe
73 fficient asymmetric synthesis of a selective estrogen receptor modulator (SERM) that has a dihydroben
74 xifene (BZA) is a third-generation selective estrogen receptor modulator (SERM) that has been approve
75 xyphenyl)]be nzo[b]thiophene) is a selective estrogen receptor modulator (SERM) that is a potent estr
76 eplacement therapy (CRT) (n = 16), selective estrogen receptor modulator (SERM) therapy (n = 8), and
77                                The selective estrogen receptor modulator (SERM) toremifene was previo
78 benzothiophene raloxifene, 1, is a selective estrogen receptor modulator (SERM) which is currently un
79         Trioxifene (LY133314) is a selective estrogen receptor modulator (SERM) with competitive bind
80                       Tamoxifen, a selective estrogen receptor modulator (SERM), represents the stand
81  SP500263, a novel next-generation selective estrogen receptor modulator (SERM), tamoxifen, and ralox
82 st cancer therapeutic, is a tissue-selective estrogen receptor modulator (SERM), which acts as an ant
83 -a novel, potent, third-generation selective estrogen receptor modulator (SERM)-because this benzothi
84         Idoxifene (ID) is a tissue-selective estrogen receptor modulator (SERM).
85 at 27HC functions as an endogenous selective estrogen receptor modulator (SERM).
86  We tested whether the therapeutic selective estrogen receptor modulators (SERM), raloxifene and tamo
87 , but surprisingly antagonists and selective estrogen receptor modulators (SERMs) activated the AF-2
88 nificant recent findings regarding selective estrogen receptor modulators (SERMs) and selective andro
89 uvant endocrine therapy, including selective estrogen receptor modulators (SERMs) and/or aromatase in
90                                    Selective Estrogen Receptor Modulators (SERMs) are a new class of
91  the potential of estrogens and 17 Selective Estrogen Receptor Modulators (SERMs) as inhibiting ligan
92                                    Selective estrogen receptor modulators (SERMs) demonstrate tissue-
93                                    Selective estrogen receptor modulators (SERMs) extend estrogen rec
94 l activity of natural estrogens or selective estrogen receptor modulators (SERMs) has not been determ
95                                    Selective estrogen receptor modulators (SERMs) have been defined a
96 itional approaches to discovery of selective estrogen receptor modulators (SERMs) have relied on ER b
97                         When using selective estrogen receptor modulators (SERMs) in cancer therapy,
98 Tamoxifen and its analogues act as selective estrogen receptor modulators (SERMs) in women, with estr
99                      Estrogens and selective estrogen receptor modulators (SERMs) interact with estro
100 enic and antiestrogenic effects of selective estrogen receptor modulators (SERMs) is thought to under
101                                    Selective estrogen receptor modulators (SERMs) mimic estrogen acti
102 ittle is known about the impact of selective estrogen receptor modulators (SERMs) on the brain.
103                                    Selective estrogen receptor modulators (SERMs) partially avoid suc
104  of 2,400 compounds, we noted that selective estrogen receptor modulators (SERMs) potently stabilize
105                                    Selective estrogen receptor modulators (SERMs) show differential e
106                                    Selective estrogen receptor modulators (SERMs) such as tamoxifen a
107 gen's action and determine whether selective estrogen receptor modulators (SERMs) such as tamoxifen h
108  the mechanism(s) of action of the Selective Estrogen Receptor Modulators (SERMs) tamoxifen and ralox
109 e of a class of compounds known as selective estrogen receptor modulators (SERMs) that possess estrog
110                                    Selective estrogen receptor modulators (SERMs) that suppress bone
111                 Evaluation of nine selective estrogen receptor modulators (SERMs) via cellular and bi
112                 The interaction of selective estrogen receptor modulators (SERMs) with lipid membrane
113 he ovariectomized rat by estrogen, selective estrogen receptor modulators (SERMs), and bisphosphonate
114                                The selective estrogen receptor modulators (SERMs), including 4-hydrox
115 rogram aimed at the development of selective estrogen receptor modulators (SERMs), novel chromene sca
116 eral FDA-approved drugs, including selective estrogen receptor modulators (SERMs), possess selective
117      Current interventions include selective estrogen receptor modulators (SERMs), prophylactic surge
118 en assessed the suitability of the selective estrogen receptor modulators (SERMs), raloxifene and tam
119                                    Selective estrogen receptor modulators (SERMs), such as tamoxifen
120 they are more appropriately called selective estrogen receptor modulators (SERMs).
121 eate dual aromatase inhibitor (AI)/selective estrogen receptor modulators (SERMs).
122 ective pharmacology of an array of selective estrogen receptor modulators (SERMs).
123 n action at the estrogen receptor (selective estrogen receptor modulators (SERMs]); or (2) inhibit es
124  a key determinant of estrogen and selective estrogen receptor modulator signaling in the ERalpha/AP-
125                                    Selective estrogen receptor modulators such as tamoxifen have tiss
126 enyl)-propionitrile (DPN), and the selective estrogen receptor modulator tamoxifen (Tam), inhibit est
127 promoted hormone resistance to the selective estrogen receptor modulator tamoxifen and selective estr
128                  Resistance to the selective estrogen receptor modulator tamoxifen and to aromatase i
129 east cancer cells were more resistant to the estrogen receptor modulator tamoxifen as a result of inc
130                                The selective estrogen receptor modulator tamoxifen has been used for
131                                The selective estrogen receptor modulator tamoxifen is used for the pr
132                                The selective estrogen receptor modulator tamoxifen was also administe
133  CNS-permeant PKC inhibitor is the selective estrogen receptor modulator tamoxifen.
134 or breast cancer-specifically, the selective estrogen receptor modulators tamoxifen and raloxifene.
135           Hormone therapy with the selective estrogen-receptor modulator tamoxifen provides a tempora
136 ects on uterine development of the selective estrogen receptor modulators, tamoxifen, toremifene, and
137 SCs) into myofibroblasts is inhibited by the estrogen-receptor modulator, tamoxifen, which activates
138      Raloxifene hydrochloride is a selective estrogen receptor modulator that has antiestrogenic effe
139                    Raloxifene is a selective estrogen receptor modulator that has estrogen-agonistic
140               Tamoxifen (TMX) is a selective estrogen receptor modulator that is used as an estrogen
141  Phytoestrogens may act as natural selective estrogen receptor modulators that elicit distinct clinic
142 ne and TSE-424 are investigational selective estrogen receptor modulators that have been shown to be
143       Tamoxifen and raloxifene are selective estrogen receptor modulators that have been shown to red
144 ion, tamoxifen and raloxifene, two selective estrogen receptor modulators that have protective effect
145            Four of them were known selective estrogen receptor modulators that were never reported as
146  inhibitors, fenretinide, or other selective estrogen receptor modulators to lower BC risk is not rec
147 tate the design of tissue-specific selective estrogen receptor modulators to treat breast cancers and
148 the ERbeta-mediated agonism of all selective estrogen receptor modulators was present.
149 se 27HC functions as an endogenous selective estrogen receptor modulator, we hypothesize that 27HC bi
150 benzothiophene raloxifene, 1, is a selective estrogen receptor modulator which is currently under cli
151               Tamoxifen (TAM) is a selective estrogen receptor modulator widely used in the preventio
152 ell defined forms of estrogens and selective estrogen receptor modulators will continue to provide no
153 s may provide means to develop new selective estrogen receptor modulators with improved profiles.
154 soflavones are naturally occurring selective estrogen receptor modulators, with potential bone protec

 
Page Top